Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7353

1.

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives.

Oeckl P, Steinacker P, Feneberg E, Otto M.

Biochim Biophys Acta. 2014 Dec 16. pii: S1570-9639(14)00326-4. doi: 10.1016/j.bbapap.2014.12.010. [Epub ahead of print] Review.

PMID:
25526887
[PubMed - as supplied by publisher]
2.

Bone Marrow-Derived Endothelial Progenitor Cells Protect Against Scopolamine-Induced Alzheimer-Like Pathological Aberrations.

Safar MM, Arab HH, Rizk SM, El-Maraghy SA.

Mol Neurobiol. 2014 Dec 21. [Epub ahead of print]

PMID:
25526861
[PubMed - as supplied by publisher]
3.

Cognition, Brain Atrophy, and Cerebrospinal Fluid Biomarkers Changes from Preclinical to Dementia Stage of Alzheimer's Disease and the Influence of Apolipoprotein E.

Susanto TA, Pua EP, Zhou J.

J Alzheimers Dis. 2014 Dec 12. [Epub ahead of print]

PMID:
25524955
[PubMed - as supplied by publisher]
4.

Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index.

Hall A, Mattila J, Koikkalainen J, Lötjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frölich L, Hampel H, Visser PT, Soininen H.

Curr Alzheimer Res. 2014 Dec 18. [Epub ahead of print]

PMID:
25523428
[PubMed - as supplied by publisher]
5.

Turmeric improves post-prandial working memory in pre-diabetes independent of insulin.

Lee MS, Wahlqvist ML, Chou YC, Fang WH, Lee JT, Kuan JC, Liu HY, Lu TM, Xiu L, Hsu CC, Andrews ZB, Pan WH.

Asia Pac J Clin Nutr. 2014;23(4):581-91. doi: 10.6133/apjcn.2014.23.4.24.

PMID:
25516316
[PubMed - in process]
Free Article
6.

Plasma Metabolic Profiling of Mild Cognitive Impairment and Alzheimer's Disease using Liquid Chromatography/Mass Spectrometry.

Liu YI, Naijing LI, Zhou LI, Zhou L, Qing LI.

Cent Nerv Syst Agents Med Chem. 2014 Dec 16. [Epub ahead of print]

PMID:
25515716
[PubMed - as supplied by publisher]
7.

Randomized denoising autoencoders for smaller and efficient imaging based AD clinical trials.

Ithapul VK, Singh V, Okonkwo O, Johnson SC.

Med Image Comput Comput Assist Interv. 2014;17(Pt 2):470-8.

PMID:
25513545
[PubMed - in process]
8.

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B.

Nat Rev Neurol. 2014 Dec 16. doi: 10.1038/nrneurol.2014.232. [Epub ahead of print] Review.

PMID:
25511894
[PubMed - as supplied by publisher]
9.

Biomarkers of Parkinson's disease (PD): Present and future.

Miller DB, O'Callaghan JP.

Metabolism. 2014 Oct 31. pii: S0026-0495(14)00339-4. doi: 10.1016/j.metabol.2014.10.030. [Epub ahead of print]

PMID:
25510818
[PubMed - as supplied by publisher]
10.

Down syndrome and Alzheimer's disease: Common pathways, common goals.

Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm AC, Iqbal K, Krams M, Lemere C, Lott I, Mobley W, Ness S, Nixon R, Potter H, Reeves R, Sabbagh M, Silverman W, Tycko B, Whitten M, Wisniewski T.

Alzheimers Dement. 2014 Dec 12. pii: S1552-5260(14)02860-X. doi: 10.1016/j.jalz.2014.10.007. [Epub ahead of print]

PMID:
25510383
[PubMed - as supplied by publisher]
11.

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease.

Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC.

Alzheimers Dement. 2014 Dec 12. pii: S1552-5260(14)02862-3. doi: 10.1016/j.jalz.2014.10.008. [Epub ahead of print] Review.

PMID:
25510382
[PubMed - as supplied by publisher]
12.

[Biochip for determination of genetic markers of sporadic Alzheimer's disease in the Russian Slavic population].

[No authors listed]

Mol Biol (Mosk). 2013 Nov-Dec;47(6):949-58. Russian.

PMID:
25509857
[PubMed - in process]
13.

Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis.

Farrokhi V, Nemati R, Nichols FC, Yao X, Anstadt E, Fujiwara M, Grady J, Wakefield D, Castro W, Donaldson J, Clark RB.

Clin Transl Immunology. 2013 Nov 15;2(11):e8. doi: 10.1038/cti.2013.11. eCollection 2013 Nov.

PMID:
25505950
[PubMed]
Free PMC Article
14.

Translational Study of Alzheimer's Disease (AD) Biomarkers from Brain Tissues in AβPP/PS1 Mice and Serum of AD Patients.

Sun Y, Rong X, Lu W, Peng Y, Li J, Xu S, Wang L, Wang X.

J Alzheimers Dis. 2014 Dec 10. [Epub ahead of print]

PMID:
25502766
[PubMed - as supplied by publisher]
15.

Supervised Discriminative Group Sparse Representation for Mild Cognitive Impairment Diagnosis.

Suk HI, Wee CY, Lee SW, Shen D.

Neuroinformatics. 2014 Dec 16. [Epub ahead of print]

PMID:
25501275
[PubMed - as supplied by publisher]
16.

The Effect of TOMM40 Poly-T Repeat Lengths on Age of Onset and Cerebrospinal Fluid Biomarkers in Finnish Alzheimer's Disease Patients.

Helisalmi S, Hall A, Meriläinen EH, Väisänen V, Koivisto AM, Herukka SK, Laitinen M, Soininen H, Hiltunen M.

Neurodegener Dis. 2014 Dec 4. [Epub ahead of print]

PMID:
25500937
[PubMed - as supplied by publisher]
17.

Anxiety Symptoms in Amnestic Mild Cognitive Impairment Are Associated with Medial Temporal Atrophy and Predict Conversion to Alzheimer Disease.

Mah L, Binns MA, Steffens DC; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2014 Oct 29. pii: S1064-7481(14)00306-6. doi: 10.1016/j.jagp.2014.10.005. [Epub ahead of print]

PMID:
25500120
[PubMed - as supplied by publisher]
18.

Tau imaging: early progress and future directions.

Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC.

Lancet Neurol. 2015 Jan;14(1):114-124. doi: 10.1016/S1474-4422(14)70252-2. Review.

PMID:
25496902
[PubMed - as supplied by publisher]
19.

An integrated workflow for multiplex CSF proteomics and peptidomics - identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

Hölttä M, Minthon L, Hansson O, Holmen-Larsson J, Pike I, Ward M, Kuhn K, Zetterberg H, Blennow K, Gobom J.

J Proteome Res. 2014 Dec 9. [Epub ahead of print]

PMID:
25490617
[PubMed - as supplied by publisher]
20.

Detection of retinal nerve fibre layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers.

Tas A, Yolcu U, Ilhan A, Gundogan FC.

Acta Ophthalmol. 2014 Dec 9. doi: 10.1111/aos.12614. [Epub ahead of print] No abstract available.

PMID:
25488510
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk